SUPN fund manager activity
Supernus Pharmaceuticals, Inc · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q1 2015 to Q2 2026.
Q2 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Trimmed | 17,623 | $555,477 | 0.00% | Aug 14, 2025 |
| Third Avenue Management | No change | 189,493 | $5,972,819 | 1.23% | Aug 13, 2025 |
Q1 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Trimmed | 30,683 | $1,004,868 | 0.01% | May 15, 2025 |
| Third Avenue Management | No change | 189,493 | $6,205,896 | 1.24% | May 14, 2025 |